ASSIST Registry Studying Various Operator Techniques
Launched by STRYKER NEUROVASCULAR · Feb 15, 2019
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
ASSIST is a prospective, global, consecutive enrollment Registry of anterior circulation acute ischemic stroke patients with an LVO who undergo treatment with one of the interventional techniques using Stryker Neurovascular devices for the first pass. The purpose of this Registry is to assess the procedural success and clinical outcomes associated with various operator techniques for mechanical thrombectomy in large vessel occlusions (LVO) in the anterior circulation. Data will be collected on the use of Stryker market-released neurovascular mechanical access and mechanical thrombectomy dev...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects who experienced acute ischemic stroke (AIS), eligible for restoration of blood flow using Stryker Neurovascular market-released products in the neurovasculature to remove thrombus
- • 2. Occlusion of intracranial anterior circulation vessel
- • 3. Subject or subject's legally authorized representative (LAR) has signed the informed consent form prior to or within 48 hours post-procedure
- • 4. Subject is willing to comply with the protocol follow-up requirements
- • 5. The intended technique and treated technique must be one of the following techniques for the first thrombectomy pass in the neurovasculature per Instructions For Use (IFU): Technique Category/Devices: SR Classic/SR + BGC, SR Combination/SR + Asp Cath ± Pump + BGC or LS, Direct Aspiration/Asp Cath ± Pump + BGC or LS,
- Exclusion Criteria:
- • The subject is participating in another device trial or any other clinical trial where the study procedure or treatment might confound this study's endpoint.
About Stryker Neurovascular
Stryker Neurovascular is a leading medical technology company focused on developing innovative solutions for the treatment of neurovascular conditions. As a subsidiary of Stryker Corporation, it specializes in advanced products and therapies aimed at improving patient outcomes in the fields of stroke intervention and surgical treatment of neurovascular diseases. With a commitment to research and development, Stryker Neurovascular works collaboratively with healthcare professionals to deliver cutting-edge technologies that enhance procedural efficiency and safety, ultimately striving to transform the standard of care in neurovascular medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Royal Oak, Michigan, United States
Valhalla, New York, United States
Danville, Pennsylvania, United States
Indianapolis, Indiana, United States
Lausanne, , Switzerland
Kansas City, Kansas, United States
Los Angeles, California, United States
Pittsburgh, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Madrid, , Spain
Providence, Rhode Island, United States
Hollywood, Florida, United States
Madrid, , Spain
Basel, , Switzerland
Santander, , Spain
Charleston, South Carolina, United States
Gwangju, , Korea, Republic Of
Kassel, , Germany
Heidelberg, , Germany
Modesto, California, United States
Gent, , Belgium
Stanford, California, United States
Munich, , Germany
Rouen, , France
Dortmund, , Germany
Toledo, Ohio, United States
Orange, California, United States
New York, New York, United States
Suwon, , Korea, Republic Of
Roma, , Italy
Harlingen, Texas, United States
Jacksonville, Florida, United States
Worcester, Massachusetts, United States
Milwaukee, Wisconsin, United States
Genova, , Italy
Barcelona, , Spain
Toronto, , Canada
Geneva, , Switzerland
Mesa, Arizona, United States
Fontana, California, United States
Los Angeles, California, United States
Rancho Cordova, California, United States
Delray Beach, Florida, United States
Tampa, Florida, United States
Marietta, Georgia, United States
Oak Lawn, Illinois, United States
Flint, Michigan, United States
Lansing, Michigan, United States
Buffalo, New York, United States
Columbus, Ohio, United States
Oklahoma City, Oklahoma, United States
Portland, Oregon, United States
Memphis, Tennessee, United States
El Paso, Texas, United States
Morgantown, Virginia, United States
Ostend, , Belgium
Hradec Králové, , Czechia
Bordeaux, , France
Brest, , France
Bron, , France
Munich, , Germany
Recklinghausen, , Germany
Messina, , Italy
Parma, , Italy
Siena, , Italy
Via Giardini, , Italy
Valladolid, Castilla Leon, Spain
Oviedo, Vigo, Spain
Madrid, , Spain
Palma De Mallorca, , Spain
London, , United Kingdom
Patients applied
Trial Officials
Rishi Gupta, MD
Principal Investigator
WellStar Medical Group
Markus Möhlenbruch, MD
Principal Investigator
University Hospital Heidelberg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials